Actuate Therapeutics, Inc. SEC filings ACTU
Actuate Therapeutics, Inc. has 192 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 2, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2026 | — |
| 4 | Insider transaction | Oct 30, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 29, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 3 | Initial insider ownership | May 6, 2026 | May 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 17, 2025 | — |
| 144 | Notice of proposed sale | Dec 11, 2025 | — |
| 4 | Insider transaction | Jun 30, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 27, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 27, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4/A | Ownership document | Aug 20, 2024 | Aug 12, 2024 |
| 4/A | Ownership document | Aug 20, 2024 | Aug 12, 2024 |
| 4/A | Ownership document | Aug 20, 2024 | Aug 12, 2024 |
| SC 13D | Ownership over 5% (active) | Aug 19, 2024 | — |
| 4 | Insider transaction | Aug 16, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 14, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACTU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Worth, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1652935
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.